OakChart

Envista Holdings Corp

NVSTHealthcare·Medical Instruments & Supplies·USA·Mid·NYSE·Nov 11 • 2:14 PM ET

25.49-0.35 (-1.35%)
2026-11-11 20:14 CET
Market cap
4,143.31 USD m
Revenue, TTM
2,878.10 USD m
Net income, TTM
633.60 USD m
Free cash flow, TTM
242.00 USD m
EPS diluted, TTM
3.87
P/E
6.59
Compare

Price

NVST against its 20, 50 and 200-day averages
2050200beat
22.0024.0026.0028.003.5M7.0MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26NVSTclose 25.4920-day 24.3150-day 24.31200-day 25.7825.49

16.2% under the 52-week high of 30.42 on 11 Feb 2026. 52-week low 18.77 on 18 Nov 2025. Last 15 sessions, 19.5% high to low

Profile

NVST
52-week range, 58% of the way up
18.7730.42

Envista Holdings Corp. engages in the manufacturing and marketing of dental products, diagnostics, treatment, and trading. It offers dental consumables, equipment, and services to dental professionals. It operates through the Specialty Products and Technologies, and Equipment and Consumables segments. The Specialty Products and Technologies segment develops, manufactures, and markets dental implant systems, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment and Consumables segments refers to developing, manufacturing, and marketing dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization and magnification systems, handpieces and associated consumables, treatment units and other dental practice equipment, endodontic systems, and related consumables, restorative materials and instruments, rotary burs, impression materials, bonding agents and cements, and infection prevention products. The company was founded on August 29, 2018 and is headquartered in Brea, CA.

IndexRUI
Employees12000
IPOSep 18, 2019
Beta0.93
ATR, 14d1.02
Rel volume0.33
Short float6.21%
Insider own2.36%
Inst own118.26%

Snapshot

6 groups

Valuation

IndexRUI
Market Cap4.09B
Enterprise Value4.52B
Income633.60M
Sales2.88B
Book/sh19.27
Cash/sh7.23
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees12000
IPOSep 18, 2019

Ratios

P/E6.59
Forward P/E15.23
PEG1.01
P/S1.42
P/B1.32
P/C3.53
P/FCF16.89
EV/EBITDA10.17
EV/Sales1.57
Quick Ratio2.10
Current Ratio2.45
Debt/Eq0.51
LT Debt/Eq0.50
Option/ShortYes / Yes

Earnings

EPS (ttm)3.87
EPS next Y1.67
EPS next Q0.40
EPS this Y31.11%
EPS next Y7.24%
EPS next 5Y15.14%
EPS past 3/5Y-40.82% 6.49%
Sales past 3/5Y1.91% 7.11%
EPS Y/Y TTM4511.50%
Sales Y/Y TTM9.78%
EPS Q/Q1805.48%
Sales Q/Q3.22%
EarningsNov 04 AMC
EPS/Sales Surpr.12.42% 0.40%

Ownership

Insider Own2.36%
Insider Trans-0.21%
Inst Own118.26%
Inst Trans6.76%
ROA11.26%
ROE20.52%
ROIC13.66%
Gross Margin56.46%
Oper. Margin11.55%
Profit Margin22.01%
SMA204.87%
SMA504.83%
SMA200-1.13%
Trades-

Technical

Shs Outstand160.30M
Shs Float156.55M
Short Float6.21%
Short Ratio3.35
Short Interest9.73M
52W High30.42 -16.21%
52W Low18.77 35.80%
Volatility6.38% 3.95%
ATR (14)1.02
RSI (14)55.91
Beta0.93
Rel Volume0.33
Avg Volume2.90M
Volume720,087

Performance

Perf Week-6.25%
Perf Month12.54%
Perf Quarter-9.22%
Perf Half Y6.56%
Perf YTD17.41%
Perf Year26.13%
Perf 3Y18.17%
Perf 5Y-40.54%
Perf 10Y-
Recom2.19
Target Price28.92
Prev Close25.84
Price25.49
Change %-1.35%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Oct 15, 2026DowngradeRRobert W. BairdOutperform → Neutral$26+2.0%
Sep 03, 2026UpgradeJJP MorganNeutral → Overweight$32+25.5%
Jul 09, 2026InitiatedBBMO Capital MarketsMarket Perform$27+5.9%
Apr 15, 2026InitiatedCCitigroupNeutral$29+13.8%
Feb 06, 2026UpgradeLLeerink PartnersMarket Perform → Outperform$35+37.3%
Dec 09, 2025InitiatedBBarclaysOverweight$24-5.8%
May 27, 2025UpgradeRRobert W. BairdNeutral → Outperform$23-9.8%
Dec 04, 2024InitiatedMMizuhoUnderperform$20-21.5%
Oct 31, 2024UpgradeLLeerink PartnersUnderperform → Market Perform$16 → $23-9.8%
Oct 08, 2024InitiatedWWells FargoEqual Weight$20-21.5%

Peers

Mkt cap
TickerCompanyMkt cap
XRAYDENTSPLY Sirona Inc1.94B
ALGNAlign Technology Inc12.07B
SOLVSolventum Corp15.16B
HSICHenry Schein Inc9.72B
COOCooper Companies Inc11.96B
BLCOBausch + Lomb Corp7.62B
TFXTeleflex Incorporated6.17B
MLSSMilestone Scientific Inc26.99M
STESteris Plc24.79B
ZBHZimmer Biomet Holdings Inc20.19B

Insider trading

5 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Reis MischaSVP, Strategy & Bus. Dev.Aug 20 '26Sale27.508,000220,00027,321Aug 24 04:25 PM
Reis MischaOfficerAug 20 '26Proposed Sale27.508,000220,000Aug 20 01:28 PM
Reis MischaSVP, Strategy & Bus. Dev.Feb 10 '26Option Exercise17.259,675166,91638,016Feb 11 05:15 PM
Reis MischaSVP, Strategy & Bus. Dev.Feb 10 '26Sale30.009,675290,25032,382Feb 11 05:15 PM
Reis MischaOfficerFeb 10 '26Proposed Sale30.009,675290,250Feb 10 12:40 PM

Held by

AUM
TickerCompanyAUM
IJHiShares Core S&P Mid-Cap ETFAUM: 124.48B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
DFSVUS Small Cap Value Portfolio ETF Class SharesAUM: 8.52B
DFATU.S. Targeted Value Portfolio-ETF Class SharesAUM: 14.47B
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.76B
VXFVanguard Extended Market Index ETFAUM: 30.47B
MDYState Street SPDR S&P MIDCAP 400 ETF TrustAUM: 26.22B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.51B
SPMDState Street SPDR Portfolio S&P 400TM Mid Cap ETFAUM: 18.90B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-040.4000.3563.110691.5688.7415
2026Q22026-08-050.4100.3350.327730.5716.1116
2026Q12026-05-060.3600.3120.233705.5680.0315
2025Q42026-02-050.3800.3230.198750.6679.9815
2025Q32025-10-300.3200.276-0.182669.9640.7914
2025Q22025-07-310.2600.2320.155682.1640.0114
2025Q12025-05-010.2400.2030.104616.9606.3614
2024Q42025-02-050.2400.2220.007652.9645.8514
2024Q32024-10-300.1200.0880.047601590.3413
2024Q22024-08-070.1100.269-6.692633.1646.8812
2024Q12024-05-010.2600.3160.136623.6634.8513
2023Q42024-02-070.2900.341-1.266645.6638.8411
2023Q32023-11-010.4300.4530.123631.3643.8510
2023Q22023-08-020.4300.4100.294662.4655.8110
2023Q12023-05-030.3800.4130.247627.2632.5110
2022Q42023-02-080.5200.4880.419660.8658.410

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY1.7901.7341.5952,7522,764
2020FY0.9800.8290.2032,2822,217
2021FY1.8501.8191.8512,5092,493
2022FY1.9401.9081.3402,5692,568
2023FY1.5301.583-0.6002,5672,557
2024FY0.7300.715-6.4962,5112,504
2025FY1.1901.1450.2802,7202,645
2026FY-1.560--2,873
2027FY-1.673--2,965
2028FY-1.817--3,083
2029FY-1.970--3,159

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0513010744.82738.3754.2
2026Q4S2026-11-041332752.99738.03768.1
2026Q4S2026-10-231332752.99738.03768.1
2026Q4S2026-10-201332753.16740.29768.1
2026Q4S2026-10-0913102753.16740.29768.1
2026Q4S2026-10-0813102753.16740.29768.1
2026Q4S2026-10-0713102752.78740.29768.1
2026Q4S2026-10-0213101753.55740.29768.1
2026Q4S2026-10-0113110754.77740.29768.1
2026Q4S2026-09-2813110754.61740.29768.1
2026Q4S2026-09-2513100753.81740.29768.1
2026Q4S2026-09-2414110753.28740.29768.1
2026Q4S2026-09-2314100752.8740.29768.1
2026Q4S2026-09-171490752.26740.29768.1

Estimate history

EPS, annual1.8981.4541.5950.2031.8511.34-0.6-6.4960.2783.8688
Period201720182019202020212022202320242025TTM
EPS, quarterly0.0470.0070.1040.155-0.1820.1980.2330.3273.111
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual2810.92844.52751.61929.12508.92569.12566.52510.62719.52878.1
Period201720182019202020212022202320242025TTM
Sales, quarterly601652.9616.9682.1669.9750.6705.5730.5691.5
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual158.651158.651158.7160161.6163.2171.5172.2163.8160.3
Period201720182019202020212022202320242025MRQ
Shares, quarterly172172.2171.5166.8165163.8162.9160.6160.3
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue2,878.102,719.502,510.602,566.502,569.102,508.901,929.102,751.602,844.50
Cost of Goods Sold Incl. D&A1,253.001,223.201,132.001,116.001,080.701,035.70856.001,235.501,234.90
Gross Profit1,625.101,496.301,378.601,450.501,488.401,473.201,073.101,516.101,609.60
Selling, General and Administrative Excl. Other1,292.601,250.901,235.501,125.601,117.101,073.60918.401,225.601,287.50
Research and Development121.80114.0099.1093.80100.10100.5086.70154.70172.00
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income332.50245.40143.10324.90371.30399.60154.70290.50322.10
Interest Expense34.2036.6046.4063.4038.4054.1062.503.500.00
Unusual Expense34.9029.301,181.30321.9052.1093.40111.2013.0023.70
Net Income Before Taxes684.40177.20-1,084.70-54.90283.90254.50-20.00275.50301.10
Income Taxes50.80130.2033.9045.3045.90-9.00-62.5057.9070.40
Consolidated Net Income633.6047.00-1,118.60-100.20238.00263.5042.50217.60230.70
Net Income From Continuing Operations633.6047.00-1,118.60-100.20238.00263.5042.50217.60230.70
Net Income633.6047.00-1,118.60-100.20238.00328.8033.30217.60230.70
EPS (Recurring)4.030.40-1.690.751.552.220.681.661.56
EPS (Basic, Before Extraordinaries)3.930.28-6.50-0.601.462.040.211.601.45
EPS (Diluted)3.870.28-6.50-0.601.341.850.201.601.45
EBITDA444.00361.40266.20487.50533.40551.50317.80458.60452.10
Non-Operating Income (Expense)421.00-2.30-0.105.503.102.40-1.001.502.70
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense48.1129.7027.8924.2524.0920.2216.2114.409.71
Price To Earnings Ratio6.686.68-22.2125.1924.35210.0220.3820.55
Price To Sales Ratio1.331.351.321.562.333.192.871.47-
Gross Margin56.4655.0254.9156.5257.9358.7255.6355.1056.59
Operating Margin11.559.025.7012.6614.4515.938.0210.5611.32
Net Margin22.011.73-44.56-3.909.2613.111.737.918.11
Shares Outstanding160.30163.80172.20171.50163.20161.60160.00158.70158.65
Market Capitalization4,143.314,143.313,319.754,123.935,489.737,271.245,384.724,702.424,645.30

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue691.50730.50705.50750.60669.90682.10616.90652.90
Cost of Goods Sold Incl. D&A287.00316.20312.30337.50294.80311.90279.00279.60
Gross Profit404.50414.30393.20413.10375.10370.20337.90373.30
Selling, General and Administrative Excl. Other310.30325.80323.90332.60310.30319.40288.60314.00
Research and Development29.3030.4030.0032.1028.3028.3025.3026.70
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income94.2088.5069.3080.5064.8050.8049.3059.30
Interest Expense7.808.707.4010.309.008.009.309.90
Unusual Expense14.708.204.807.207.304.5010.3013.20
Net Income Before Taxes500.2074.4052.2057.6049.9040.7029.0036.50
Income Taxes-8.1020.7013.5024.7080.2014.3011.0035.30
Consolidated Net Income508.3053.7038.7032.90-30.3026.4018.001.20
Net Income From Continuing Operations508.3053.7038.7032.90-30.3026.4018.001.20
Net Income508.3053.7038.7032.90-30.3026.4018.001.20
EPS (Recurring)3.170.360.250.23-0.150.170.150.06
EPS (Basic, Before Extraordinaries)3.160.330.240.20-0.180.160.100.01
EPS (Diluted)3.110.330.230.20-0.180.160.100.01
EBITDA119.60116.3098.50109.6094.0080.6077.2087.10
Non-Operating Income (Expense)428.502.80-4.90-5.401.402.40-0.700.30
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense9.017.9810.5920.541.03-6.2420.30
Price To Earnings Ratio6.6865.2792.29259.6965.00---
Price To Sales Ratio1.331.591.531.331.291.311.181.33
Gross Margin58.5056.7155.7355.0455.9954.2754.7757.18
Operating Margin13.6212.119.8210.729.677.457.999.08
Net Margin73.517.355.494.38-4.523.872.920.18
Shares Outstanding160.30160.60162.90163.80165.00166.80171.50172.20
Market Capitalization4,143.314,287.884,157.513,569.693,385.133,311.782,971.963,319.75

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments1,211.701,069.10940.00606.901,073.60888.90211.200.000.00
Short Term Receivables429.60363.00407.50393.50331.90301.70443.60459.80463.10
Inventories288.10241.00258.80300.80263.80216.00277.90278.70275.70
Other Current Assets97.20115.20137.40123.40166.50184.0069.2048.3055.70
Total Current Assets2,026.601,788.301,743.701,424.601,835.801,590.601,001.90786.80794.50
Net Property, Plant & Equipment438.90419.80434.70425.40392.20437.30490.40261.60231.20
Total Investments and Advances28.8026.400.000.000.000.000.000.000.00
Intangible Assets2,985.402,911.804,246.204,583.304,178.404,360.104,591.604,715.804,885.90
Deferred Tax Assets175.70186.60185.70160.50160.50184.50-130.80143.20
Other Assets113.10117.80113.10128.807.30303.5074.40-53.40-62.00
Total Assets5,768.505,450.706,723.406,722.606,574.206,876.006,158.305,841.605,992.80
Short Term Debt Incl. Current Port. of LT Debt39.00150.50145.60537.00456.10917.9030.600.000.00
Accounts Payable191.60174.60179.50228.30185.80202.50208.00217.40222.40
Other Current Liabilities622.00553.60455.70471.40566.30564.30470.60423.60405.80
Total Current Liabilities852.60878.70780.801,236.701,208.201,684.70709.20641.00628.20
Long Term Debt1,558.701,397.201,508.00992.101,003.801,060.301,507.000.000.00
Provision for Risks Charges40.5031.2031.8018.8042.9061.500.000.000.00
Deferred Tax Liabilities89.50100.20118.30135.60-----
Other Liabilities120.90108.60110.60132.50261.30348.50399.30374.20370.00
Total Liabilities2,662.202,515.902,549.502,515.702,516.203,155.002,615.501,015.20998.20
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity3,106.302,934.804,173.904,206.904,057.603,720.603,540.204,823.104,990.50
Total Shareholders Equity3,106.302,934.804,173.904,206.904,057.603,720.603,540.204,823.104,990.50
Accumulated Minority Interest0.000.000.000.000.400.402.603.304.10
Total Equity3,106.302,934.804,173.904,206.904,058.003,721.003,542.804,826.404,994.60
Total Liabilities & Stockholders Equity5,768.505,450.706,723.406,722.606,574.206,876.006,158.305,841.605,992.80
Book Value Per Share18.9617.0424.3425.7825.1123.2522.3130.4031.46
Tangible Book Value Per Share0.740.13-0.42-2.31-0.75-4.00-6.630.680.66
Full-Time Employees12,00012,30012,80012,70011,20012,40012,50012,800-
Price to Book Ratio1.341.080.961.391.791.451.331.32-
Return on Assets0.84-18.38-1.493.583.920.653.633.90-
Return on Equity1.56-31.47-2.395.766.781.175.204.70-
Return on Invested Capital1.01-25.82-1.764.586.500.704.314.786.03
Quick Ratio2.041.761.900.911.300.821.020.790.83
Current Ratio2.382.042.231.151.520.941.411.231.26

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income633.6047.00-1,118.60-100.20243.10340.5033.30217.60230.70
Depreciation111.50116.00123.10162.60162.10151.90163.10168.10130.00
Other Funds (Non Cash)-317.2092.401,263.60321.7049.2072.40102.7018.4013.70
Funds from Operations413.90266.80239.10347.10425.40505.80207.70395.20376.10
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-112.108.9097.40-71.40-242.70-144.2076.202.3024.00
Cash from Operating Activities301.80275.70336.50275.70182.70361.60283.90397.50400.10
Capital Expenditures-59.80-45.30-33.80-58.20-75.70-54.70-47.70-77.80-72.20
Net Assets From Acquisitions-54.300.000.000.00-696.20-2.10-40.700.000.00
Sale of Fixed Assets and Businesses2.600.500.106.1077.20324.105.301.600.00
Purchase or Sale of Investments-1.500.50-23.1010.700.000.000.000.000.00
Purchase of Investments-12.60-9.90-32.800.000.00-0.000.000.00
Sale Or Maturity of Investments11.1010.409.7010.700.000.000.000.000.00
Other Uses0.60-6.80-0.30-22.60-18.60-4.600.00-2.20-3.30
Other Sources0.600.002.501.6056.000.0014.000.000.00
Cash from Investing Activities-111.80-51.10-54.60-62.40-657.30262.70-69.10-78.40-75.50
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-131.70-163.802.4011.3021.8019.5013.80643.400.00
Repurchase of Common Pref Stock-137.30-166.600.000.000.000.000.000.000.00
Sale of Common Pref Stock5.602.802.4011.3021.8019.5013.80643.400.00
Proceedsfrom Stock Options0.000.000.000.000.000.000.00643.400.00
Issuance or Reduction of Debt, Net0.00-0.90-100.00115.40-0.20-475.70479.401,315.600.00
Change in Long Term Debt0.00-0.90-100.00115.40-0.20-475.70479.401,315.600.00
Issuance of Long Term Debt0.00115.400.00805.40124.300.00750.101,315.900.00
Reduction of Long Term Debt0.00-116.30-100.00-690.00-124.50-475.70-270.70-0.300.00
Net Financing Active Other Cash Flow-9.40-6.20-6.10-7.80-9.10-7.10-0.70-2,066.70-324.60
Other Financing Activities Uses-9.40-6.20-6.10-7.90-9.10-7.10-0.70-2,066.70-324.60
Cash from Financing Activities-141.10-170.90-103.70118.9012.50-465.60492.50-107.70-324.60
Exchange Rate Effect-24.0088.90-49.100.90-4.6026.00-29.60-0.20-
Net Change in Cash24.90142.60129.10333.10-466.70184.70677.70211.200.00
Free Cash Flow242.00230.40302.70217.50107.00306.90236.20319.70327.90
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow15.8415.9410.9718.4655.8926.0823.4312.65-
Deferred Taxes & Investment Tax Credit-11.40-29.00-37.00-29.00-59.00-91.40-8.901.70

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments1,158.801,125.601,082.801,211.701,133.901,110.60
Short Term Receivables448.50436.90436.60429.60405.90422.80
Inventories285.20290.90300.30288.10290.80281.90
Other Current Assets109.30104.6099.4097.20117.70119.60
Total Current Assets2,001.801,958.001,919.102,026.601,948.301,934.90
Net Property, Plant & Equipment454.10441.90442.30438.90436.40428.90
Total Investments and Advances18.5026.4026.4028.8028.7028.70
Intangible Assets2,936.702,966.802,992.802,985.403,008.503,035.70
Deferred Tax Assets---175.70--
Other Assets199.90204.00197.40113.10220.60236.20
Total Assets5,611.005,597.105,578.005,768.505,642.505,664.40
Short Term Debt Incl. Current Port. of LT Debt37.9038.5038.7039.0039.2036.10
Accounts Payable171.80190.20170.00191.60156.00171.80
Other Current Liabilities606.60578.60577.90622.00626.50586.00
Total Current Liabilities816.30807.30786.60852.60821.70793.90
Long Term Debt1,549.601,549.501,550.501,558.701,562.901,560.10
Provision for Risks Charges40.1040.4040.3040.5038.4035.80
Deferred Tax Liabilities---89.50--
Other Liabilities116.40123.60121.10120.90131.30135.60
Total Liabilities2,522.402,520.802,498.502,662.202,554.302,525.40
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity3,088.603,076.303,079.503,106.303,088.203,139.00
Total Shareholders Equity3,088.603,076.303,079.503,106.303,088.203,139.00
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity3,088.603,076.303,079.503,106.303,088.203,139.00
Total Liabilities & Stockholders Equity5,611.005,597.105,578.005,768.505,642.505,664.40
Book Value Per Share19.2719.1618.9018.9618.7218.82
Tangible Book Value Per Share0.950.680.530.740.480.62
Full-Time Employees---12,000--
Price to Book Ratio1.341.391.341.161.081.10
Return on Assets11.261.691.230.840.270.97
Return on Equity20.523.062.211.560.501.76
Return on Invested Capital10.961.160.840.71-0.650.56
Quick Ratio2.102.072.062.042.022.08
Current Ratio2.452.432.442.382.372.44

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income508.3053.7038.7032.90-30.3026.40
Depreciation25.4027.8029.2029.1029.2029.80
Other Funds (Non Cash)-393.1017.5027.7030.7021.2021.80
Funds from Operations140.6099.0095.6078.7046.4077.10
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-62.7020.20-98.9029.3032.3011.60
Cash from Operating Activities77.90119.20-3.30108.0078.7088.70
Capital Expenditures-16.10-14.90-12.50-16.30-10.80-12.30
Net Assets From Acquisitions0.100.00-54.400.000.000.00
Sale of Fixed Assets and Businesses1.700.800.100.000.000.00
Purchase or Sale of Investments0.500.70-2.900.200.40-0.10
Purchase of Investments-8.60-0.30-3.40-0.30-8.60-0.30
Sale Or Maturity of Investments9.101.000.500.509.000.20
Other Uses0.10-0.100.000.600.70-4.70
Other Sources0.60-0.800.800.000.000.00
Cash from Investing Activities-13.10-14.30-68.90-15.50-9.70-17.10
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-8.70-59.80-39.20-24.00-41.00-85.00
Repurchase of Common Pref Stock-10.00-60.30-42.70-24.30-42.00-85.70
Sale of Common Pref Stock1.300.503.500.301.000.70
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.00-0.90
Change in Long Term Debt0.000.000.000.000.00-0.90
Issuance of Long Term Debt0.000.000.000.000.00115.40
Reduction of Long Term Debt0.000.000.000.000.00-116.30
Net Financing Active Other Cash Flow-0.90-0.90-6.40-1.20-0.70-0.50
Other Financing Activities Uses-0.90-0.90-6.40-1.20-0.70-0.50
Cash from Financing Activities-9.60-60.70-45.60-25.20-41.70-86.40
Exchange Rate Effect-22.00-1.40-11.1010.50-4.0048.10
Net Change in Cash33.2042.80-128.9077.8023.3033.30
Free Cash Flow61.80104.30-15.8091.7067.9076.40
Price to Free Cash Flow15.8418.2819.5015.6412.8812.96

Revenue breakdown

Total Dental Equipment & Supplies revenue2024: 2.51B 2025: 2.72B
All Other Countries2024: 1.11B 2025: 1.24B
China2024: 193.50M 2025: 194.40M
United States2024: 1.20B 2025: 1.28B
Equipment and Consumables2024: 894.20M 2025: 966.70M
Specialty Products and Technologies2024: 1.62B 2025: 1.75B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-306.21%9.7M156.6M2.89M
2026-10-156.23%9.8M156.8M2.76M
2026-09-307.70%12.1M156.9M2.83M
2026-09-156.51%10.2M156.9M2.71M
2026-08-317.26%11.4M156.9M2.72M
2026-08-146.14%9.6M157.0M3.08M
2026-07-317.57%11.9M157.0M3.17M
2026-07-155.88%9.4M159.1M3.14M
2026-06-306.18%9.8M159.1M3.03M
2026-06-157.61%12.1M159.0M2.95M
2026-05-297.45%11.8M159.1M2.94M
2026-05-157.17%11.4M159.1M2.71M
2026-04-305.93%9.4M159.1M2.81M
2026-04-156.92%11.0M159.4M2.85M
2026-03-316.05%9.7M160.2M2.92M
2026-03-134.55%7.3M160.2M2.88M
2026-02-274.69%7.5M160.2M2.81M
2026-02-134.97%8.0M160.2M2.68M
2026-01-305.03%8.1M160.7M2.26M
2026-01-156.56%10.5M160.7M2.17M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call12.5012.0014.900.006.0670.000.000.914-0.1540.006
call15.008.9012.400.004.7580.000.000.891-0.1480.007
call17.506.609.900.003.7950.000.000.861-0.1370.009
call20.004.107.200.002.7790.000.000.818-0.1230.011
call22.502.554.003.401.47938.000.000.749-0.1020.013
call25.000.650.950.900.42923.001.000.599-0.0550.015
call30.000.000.150.100.7942,0100.000.105-0.0320.007
call35.000.000.400.001.3010.000.000.071-0.0390.005
put12.500.001.750.004.4480.000.00-0.085-0.1540.006
put15.000.001.750.003.5060.000.00-0.110-0.1450.007
put17.500.002.150.002.7510.000.00-0.139-0.1350.009
put20.000.001.750.352.0603.000.00-0.182-0.1200.011
put22.500.002.151.101.4180.000.00-0.251-0.1000.013
put25.000.000.950.100.7372,0000.00-0.409-0.0520.015
put30.003.105.405.001.4471.000.00-0.896-0.0290.007
put35.008.0010.400.002.0980.000.00-0.929-0.0350.005

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-10FWPFiling under Securities Act Rule 163/433 of free writing prospectuses.SEC
2026-11-10424B2SEC
2026-11-09S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuersSEC
2026-11-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-10-02SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-11-024Statement of changes in beneficial ownership of securities2026-11-01SEC
2026-10-278-KCurrent report2026-10-27SEC
2026-09-178-KCurrent report2026-09-17SEC
2026-08-274Statement of changes in beneficial ownership of securities2026-08-25SEC
2026-08-274Statement of changes in beneficial ownership of securities2026-08-25SEC
2026-08-274Statement of changes in beneficial ownership of securities2026-08-25SEC
2026-08-274Statement of changes in beneficial ownership of securities2026-08-25SEC
2026-08-244Statement of changes in beneficial ownership of securities2026-08-20SEC
2026-08-20144Filing for proposed sale of securities under Rule 144.SEC
2026-08-204Statement of changes in beneficial ownership of securities2026-08-18SEC
2026-08-204Statement of changes in beneficial ownership of securities2026-08-18SEC
2026-08-198-KCurrent report2026-08-17SEC
2026-08-133Initial statement of beneficial ownership of securities2026-08-06SEC
2026-08-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-07-03SEC
2026-08-058-KCurrent report2026-08-05SEC
2026-06-038-KCurrent report2026-05-28SEC
2026-05-28SDSpecialized Disclosure ReportSEC
2026-05-274Statement of changes in beneficial ownership of securities2026-05-25SEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-19SEC
2026-05-218-KCurrent report2026-05-19SEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-19SEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-19SEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-19SEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-19SEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-19SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-0800220.00K1
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-0200290.25K1
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
BlackRock, Inc.11.33%
DIMENSIONAL FUND ADVISORS LP6.07%
ARIEL INVESTMENTS, LLC6.03%
VANGUARD PORTFOLIO MANAGEMENT LLC4.60%
VANGUARD CAPITAL MANAGEMENT LLC4.51%
INCOME RESEARCH & MANAGEMENT4.04%
MORGAN STANLEY3.96%
Gates Capital Management, Inc.3.41%
STATE STREET CORP3.27%
ALLIANCEBERNSTEIN L.P.3.20%

Funds

Fund% owned
Equity Income Fund40.13%
iShares Convertible Bond ETF6.18%
Victory Investment Grade Convertible Fund5.56%
JPMorgan Strategic Income Opportunities Fund4.92%
State Street(R) SPDR(R) Bloomberg Convertible Securities ETF4.34%
iShares Core S&P Mid-Cap ETF3.42%
VANGUARD TOTAL STOCK MARKET INDEX FUND3.17%
VANGUARD SMALL-CAP INDEX FUND2.29%
Eaton Vance Atlanta Capital SMID-Cap Fund2.08%
Ariel Fund2.08%

OakChart. NVST. Cached 15 minutes.